Concepedia

Ann Dunne

AD

11

Publications

592

Citations

10

H-Index

2007

Active since

Affiliations

Araim Pharmaceuticals (United States)(Current)

Leiden University Medical Center

Diakonessenhuis hospital

Manchester Academic Health Science Centre

Weill Cornell Medical College in Qatar

Ann Dunne is an author at Araim Pharmaceuticals (United States) specializing in neuropathic pain, medicine, and inflammation.

Top concepts

Publications per year

2007–2020

11

Publications

11

ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes

Michael Brines, Ann Dunne, Monique van Velzen et al. · Molecular Medicine · 2014 · 141 citations · Full text

Safety and Efficacy of ARA 290 in Sarcoidosis Patients with Symptoms of Small Fiber Neuropathy: A Randomized, Double-Blind Pilot Study

Lara R. Heij, Marieke Niesters, Maarten Swartjes et al. · Molecular Medicine · 2012 · 110 citations · Full text

Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain

Daniel A. Culver, Albert Dahan, Daiva Bajorunas et al. · Investigative Ophthalmology & Visual Science · 2017 · 103 citations · Full text

ARA 290 Improves Symptoms in Patients with Sarcoidosis-Associated Small Nerve Fiber Loss and Increases Corneal Nerve Fiber Density

Albert Dahan, Ann Dunne, Maarten Swartjes et al. · Molecular Medicine · 2013 · 93 citations · Full text

ARA 290, a Peptide Derived from the Tertiary Structure of Erythropoietin, Produces Long-Term Relief of Neuropathic Pain Coupled with Suppression of the Spinal Microglia Response

Maarten Swartjes, Monique van Velzen, Marieke Niesters et al. · Molecular Pain · 2014 · 36 citations · Full text

Rows per page

1–5 of 11